These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 1613316

  • 1. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia.
    Tilly-Kiesi M, Tikkanen MJ.
    J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316
    [Abstract] [Full Text] [Related]

  • 2. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
    Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Chiesa G, Sirtori CR.
    J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
    [Abstract] [Full Text] [Related]

  • 3. Effects of lovastatin on high-density lipoprotein subfractions in hypercholesterolemic patients with peripheral vascular disease.
    Tilly-Kiesi M, Mattila SP, Tikkanen MJ.
    Angiology; 1993 Feb; 44(2):129-37. PubMed ID: 8434806
    [Abstract] [Full Text] [Related]

  • 4. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD.
    Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694
    [Abstract] [Full Text] [Related]

  • 5. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR, Franceschini G, Gianfranceschi G, Sirtori M, Montanari G, Tremoli E, Maderna P, Colli S, Zoppi F.
    J Lab Clin Med; 1987 Sep 01; 110(3):279-86. PubMed ID: 3475394
    [Abstract] [Full Text] [Related]

  • 6. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y, Kobayashi T, Yamaguchi H, Sakane H, Ozawa H, Matsuda M, Mikami Y, Mikami Y, Nakamura H.
    Artery; 1993 Sep 01; 20(1):1-18. PubMed ID: 8447724
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E.
    Hepatology; 1998 Jan 01; 27(1):175-80. PubMed ID: 9425934
    [Abstract] [Full Text] [Related]

  • 8. Sexual differences in lipoprotein composition in a family with dyslipidemic hypertension with premature atheroschlerosis: deficiency of high-density lipoprotein-L and high-density lipoprotein-M "apolipoprotein-I alone" particle.
    Hughes TA, Moore MA, Joyce M, Go RC, Segrest JP, Blackwell T.
    J Lab Clin Med; 1992 Jan 01; 119(1):57-68. PubMed ID: 1727908
    [Abstract] [Full Text] [Related]

  • 9. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
    Breier C, Lisch HJ, Drexel H, Braunsteiner H.
    Schweiz Med Wochenschr; 1984 Mar 03; 114(9):288-91. PubMed ID: 6710113
    [Abstract] [Full Text] [Related]

  • 10. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Mar 03; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 11. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ, Brun D, Gagné C, Moorjani S, Bielman P, Julien P.
    Can J Cardiol; 1991 Mar 03; 7(1):27-33. PubMed ID: 2025787
    [Abstract] [Full Text] [Related]

  • 12. [Subfractions of high density lipoproteins in relation to age].
    Richter V, Rassoul F, Purcz T, Faki R.
    Z Gerontol; 1990 Mar 03; 23(1):50-5. PubMed ID: 2327147
    [Abstract] [Full Text] [Related]

  • 13. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
    Guérin M, Dolphin PJ, Talussot C, Gardette J, Berthézène F, Chapman MJ.
    Arterioscler Thromb Vasc Biol; 1995 Sep 03; 15(9):1359-68. PubMed ID: 7670950
    [Abstract] [Full Text] [Related]

  • 14. Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
    Hung YJ, Pei D, Wu DA, Kuo SW, Fuh MM, Jeng C.
    J Formos Med Assoc; 1999 Feb 03; 98(2):104-10. PubMed ID: 10083765
    [Abstract] [Full Text] [Related]

  • 15. Fatty acyl composition of the major lipid classes of HDL2 and HDL3 of human serum.
    Devitt MM, Headon DR.
    Clin Chim Acta; 1986 Mar 28; 155(3):309-17. PubMed ID: 3708859
    [Abstract] [Full Text] [Related]

  • 16. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR, Bacon S.
    Circulation; 1989 Mar 28; 79(3):590-6. PubMed ID: 2645064
    [Abstract] [Full Text] [Related]

  • 17. Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients.
    Dachet C, Cavallero E, Martin C, Girardot G, Jacotot B.
    Atherosclerosis; 1995 Feb 28; 113(1):1-9. PubMed ID: 7755644
    [Abstract] [Full Text] [Related]

  • 18. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 19. Change in composition of high density lipoprotein during gemfibrozil therapy.
    Sorisky A, Ooi TC, Simo IE, Meuffels M, Hindmarsh JT, Nair R.
    Atherosclerosis; 1987 Oct 01; 67(2-3):181-9. PubMed ID: 3118893
    [Abstract] [Full Text] [Related]

  • 20. Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia.
    Vega GL, Grundy SM.
    JAMA; 1989 Dec 08; 262(22):3148-53. PubMed ID: 2810673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.